The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial

Intermittently Scanned Continuous Glucose Monitoring Data of Polish Patients from Real-Life Conditions: More Scanning and Better Glycemic Control Compared to Worldwide Data

(2021) Jerzy Hohendorff et al.   Diabetes Technology & Therapeutics

Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting with Continuous Glucose Monitoring: FUTURE-PEAK

(2021) Ben Broos et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters

(2021) Annel Lameijer et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

(2021) Margaretha M Visser et al.   LANCET

Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials

(2020) Maria Ida Maiorino et al.   DIABETES CARE

HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes

(2020) Roland H Stimson et al.   BMJ Open Diabetes Research & Care

Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests

(2018) Timothy C. Dunn et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial

(2018) Lutz Heinemann et al.   LANCET

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

(2017) Marcus Lind et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

(2017) Roy W. Beck et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

(2016) Anne L. Peters et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

(2016) Jan Bolinder et al.   LANCET

Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial

(2016) Cornelis A J van Beers et al.   Lancet Diabetes & Endocrinology

Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial

(2015) Andrea Tumminia et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS